1-9 of 9
Bayard Powell
Close
Sort by
Journal Articles

Feasibility of Inpatient Geriatric Assessment for Older Adults with Newly Diagnosed Acute Myelogenous Leukemia

Heidi D Klepin, MD, MS, Leslie Renee Ellis, MD, Denise Levitan, MD, Bayard Powell, MD
Journal: Blood
Blood (2008) 112 (11): 3996.
https://doi.org/10.1182/blood.V112.11.3996.3996
Published: 2008
Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) for Chronic Phase Chronic Myeloid Leukemia (CML) with Resistance to ≥2 BCR-ABL Tyrosine Kinase Inhibitors

Andrey Zaritskey, Giuliana Alimena, Lech Konopka, Jila Shamsazar, Priscille M. Bourquelot, Muhammad Jalaluddin, Martha Li, Anna Turkina, Gert J. Ossenkoppele, Stuart L. Goldberg, Bayard Powell
Journal: Blood
Blood (2008) 112 (11): 4254.
https://doi.org/10.1182/blood.V112.11.4254.4254
Published: 2008
Journal Articles

The Evaluation of Bronchoscopy in Acute Leukemia: A Retrospective Chart Review

John A Piede, MD, Leslie Renee Ellis, MD, Kevin P High, MD, MS, FACP, Doug Case, PhD, Bayard Powell
Journal: Blood
Blood (2008) 112 (11): 3990.
https://doi.org/10.1182/blood.V112.11.3990.3990
Published: 2008
Journal Articles

Secondary Acute Myeloid Leukemia (sAML) Treated with Amonafide (AS1413) + Cytarabine: Durable Responses in Poor-Risk AML

Steven L Allen, Harry P Erba, David A. Rizzieri, Margaret O’Donnell, Bayard Powell, Ante S Lundberg, John M Bennett, Robert L Capizzi
Journal: Blood
Blood (2008) 112 (11): 2968.
https://doi.org/10.1182/blood.V112.11.2968.2968
Published: 2008
Journal Articles

High Dose Cytarabine and Clofarabine (HiDAC → CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

Bayard Powell, Ralph D’Agostino, Jr., PhD, Denise Levitan, MD, Leslie Renee Ellis, MD, Susan Lyerly, PA-C, Megan Skiles, PA-C, Megan Manuel, NP, Robin Harrelson, RN, Claire Kimbrough, David Duane Hurd, MD
Journal: Blood
Blood (2008) 112 (11): 1936.
https://doi.org/10.1182/blood.V112.11.1936.1936
Published: 2008
Journal Articles

Iron Parameters in 84 MDS Patients Enrolled in a Deferasirox (Exjade®, ICL670) Multicenter Trial.

Alan F. List, Jason Esposito, Jodie Decker, Maria R. Baer, Bayard Powell, David Steensma, Azra Raza, Howard Terebelo, Jaroslaw Maciejewski, Stuart L. Goldberg, Carole Paley
Journal: Blood
Blood (2006) 108 (11): 4847.
https://doi.org/10.1182/blood.V108.11.4847.4847
Published: 2006
Journal Articles

Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.

Wendy Stock, MD, Richard Harvey, MD, Barry Moser, PhD, Dorie Sher, BS, Esther Schachter-Tokarz, BS, Matthew Myers, BS, James Slack, MD, Bayard Powell, MD, Clara D. Bloomfield, MD, Richard A. Larson, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, James Feusner, MD, Cheryl Willman, MD, Robert Gallagher, MD
Journal: Blood
Blood (2006) 108 (11): 494.
https://doi.org/10.1182/blood.V108.11.494.494
Published: 2006
Journal Articles

Incorporation of Alemtuzumab into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL) Is Feasible: A Phase I/II Study from the Cancer and Leukemia Group B (CALGB 10102).

Wendy Stock, MD, Daohai Yu, PhD, Ben Sanford, MS, Gerard Lozanski, Ph.D, Spero Cataland, MD, Ravi Vij, MD, John Byrd, MD, Bayard Powell, MD, Meir Wetzler, MD, Maher Albitar, MD, Dorie Sher, BS, Colin Edwards, MS, Eva Hoke, BS, Clara D. Bloomfield, MD, Richard A. Larson, MD
Journal: Blood
Blood (2005) 106 (11): 145.
https://doi.org/10.1182/blood.V106.11.145.145
Published: 2005
Journal Articles

Granulocyte Colony-Stimulating Factor (Filgrastim) Accelerates Granulocyte Recovery After Intensive Postremission Chemotherapy for Acute Myeloid Leukemia With Aziridinyl Benzoquinone and Mitoxantrone: Cancer and Leukemia Group B Study 9022

Joseph O. Moore, Richard K. Dodge, Philip C. Amrein, Jonathan Kolitz, Edward J. Lee, Bayard Powell, Scott Godfrey, Francisco Robert, Charles A. Schiffer
Journal: Blood
Blood (1997) 89 (3): 780–788.
https://doi.org/10.1182/blood.V89.3.780
Published: 1997